Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of Chronic Rhinosinusitis with Nasal Polyposis in the Era of Biologics
Justin C. Morse, Craig Miller, Brent A. Senior
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 873-882
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care
Cosimo Galletti, María Antonietta Barbieri, Francesco Ciodaro, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 630-630
Open Access | Times Cited: 24
Omalizumab Treatment in Uncontrolled Asthma and CRSwNP Patients, with Previous Endoscopic Sinus Surgery, to Improve Quality of Life and Endoscopic Outcomes: a Two-Year Real-Life Study
Juan M. Solano, M. Amparo Callejón, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2023) Vol. 23, Iss. 10, pp. 555-566
Closed Access | Times Cited: 12
Biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: A bicentric experience.
Gianluca Bellocchi, Antonella Loperfido, Francesco Maria Passàli, et al.
PubMed (2023) Vol. 94, Iss. 5, pp. e2023227-e2023227
Closed Access | Times Cited: 11
Public Knowledge and Factors Associated With Familiarity of Treatments for Rhinosinusitis
Tyler J. Gallagher, Rishabh Shah, Michelle Koh, et al.
OTO Open (2025) Vol. 9, Iss. 1
Open Access
The role of Staphylococcus aureus enterotoxin B in chronic rhinosinusitis with nasal polyposis
Zahra Chegini, Mojtaba Didehdar, Amin Khoshbayan, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design
Lucía De Prado Gómez, Asif Khan, Anju T. Peters, et al.
American Journal of Rhinology and Allergy (2022) Vol. 36, Iss. 6, pp. 788-795
Closed Access | Times Cited: 16
Raccomandazioni pratiche nella gestione ambulatoriale della rinosinusite cronica con poliposi nasale severa, nell’era dei biologici
Eugenio De Corso, Carlotta Pipolo, Elena Cantone, et al.
Acta Otorhinolaryngologica Italica (2023) Vol. 43, Iss. 5, pp. 324-340
Open Access | Times Cited: 10
The effect of biologics in lung function and quality of life of patients with united airways disease: A systematic review
Javier Domínguez‐Ortega, Joaquim Mullol, Francisco Javier Álvarez Gutiérrez, et al.
Journal of Allergy and Clinical Immunology Global (2023) Vol. 3, Iss. 1, pp. 100174-100174
Open Access | Times Cited: 10
The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye
Meryem Demir, Ceyda Tunakan Dalgıç, Nihal Mete, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 448-448
Open Access | Times Cited: 3
Dupilumab Adverse Events in Nasal Polyp Treatment: Analysis of FDA Adverse Event Reporting System
Austin R. Swisher, Rijul S. Kshirsagar, Nithin D. Adappa, et al.
The Laryngoscope (2021) Vol. 132, Iss. 12, pp. 2307-2313
Closed Access | Times Cited: 19
Individual exposure of ambient particulate matters and eosinophilic chronic rhinosinusitis with nasal Polyps: Dose-Response, mediation effects and recurrence prediction
Jiajia Wang, Shen Shen, Bing Yan, et al.
Environment International (2023) Vol. 177, pp. 108031-108031
Open Access | Times Cited: 7
Olfaction in nasal polyp patients after Reboot surgery: an endotype-based prospective study
Sara Costa Gomes, Tim Delemarre, Gabriële Holtappels, et al.
European Archives of Oto-Rhino-Laryngology (2022) Vol. 280, Iss. 6, pp. 2821-2830
Open Access | Times Cited: 11
Elevated body mass index increased the risk of recurrence in Chinese patients with chronic rhinosinusitis
Shaobing Xie, Sijie Jiang, Ruohao Fan, et al.
American Journal of Otolaryngology (2023) Vol. 44, Iss. 4, pp. 103841-103841
Closed Access | Times Cited: 6
A Comprehensive Review Exploring Allergic Rhinitis With Nasal Polyps: Mechanisms, Management, and Emerging Therapies
Gowtham Narasimhan, Prasad Deshmukh, Sagar S Gaurkar, et al.
Cureus (2024)
Open Access | Times Cited: 2
Circulating T Cell Subsets and ILC2s are Altered in Patients With Chronic Rhinosinusitis With Nasal Polyps After Dupilumab Treatment
Toshiyuki Matsuyama, Hideyuki Takahashi, Hiroe Tada, et al.
American Journal of Rhinology and Allergy (2022) Vol. 37, Iss. 1, pp. 58-64
Closed Access | Times Cited: 9
State of the Art Medical Management of Nasal Polyps
Kelly L. Staricha, Hawa M. Ali, Janalee K. Stokken
American Journal of Rhinology and Allergy (2023) Vol. 37, Iss. 2, pp. 153-161
Closed Access | Times Cited: 5
Consensus on the management of united airways disease with type 2 inflammation: a multidisciplinary Delphi study
Marina Blanco–Aparicio, Javier Domínguez‐Ortega, Carolina Cisneros, et al.
Allergy Asthma and Clinical Immunology (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Allergen immunotherapy: progress and future outlook
Lara Šošić, Marta Paolucci, Stephan Flory, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 7, pp. 745-769
Closed Access | Times Cited: 5
Increased B Cell-Activating Factor Expression Is Associated with Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps
Fang Zhang, Zhenhang Xu, He Xi, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 8
Improvement of Suspected Eosinophilic Otitis Media with Targeted Biologic Therapy
C. Yoonhee Ryder, Mark A. Zacharek, Christopher M. Welch
Otology & Neurotology (2023) Vol. 44, Iss. 5, pp. 462-468
Open Access | Times Cited: 4
When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case report
Marc Sabbé, F. Schleich, P. G. Janssens, et al.
Journal of Medical Case Reports (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Antibody-based therapeutics for chronic rhinosinusitis with nasal polyps
Shama Shishodia, Nora Haloob, Claire Hopkins
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 491-502
Closed Access | Times Cited: 1
Pharmacokinetic equivalence of CT‐P39 and reference omalizumab in healthy individuals: A randomised, double‐blind, parallel‐group, Phase 1 trial
Marcus Maurer, Sarbjit S. Saini, Kristi McLendon, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 7
Nasal cytology and histology in CRSwNP: Two sides of the same coin
Matteo Gelardi, Rossana Giancaspro, Michele Cassano, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Ocular Surface Adverse Events are not Associated with Dupilumab use in Nasal Polyp Treatment
Austin R. Swisher, Rijul S. Kshirsagar, Priscilla Vu, et al.
The Laryngoscope (2023) Vol. 134, Iss. 6, pp. 2602-2608
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top